Publication | Closed Access

Molecular docking and molecular dynamics studies reveal structural basis of inhibition and selectivity of inhibitors EGCG and OSU-03012 toward glucose regulated protein-78 (GRP78) overexpressed in glioblastoma

Neuro-oncologyBiochemistryG Protein-coupled ReceptorMedicineBiomolecular InteractionAnti-cancer AgentInhibitors EgcgBiomolecular EngineeringMolecular DockingGliomaTumor BiologyDrug DiscoveryMolecular Dynamics Studies